Human epidermal growth factor receptor 2 (HER2), a member of the ERBB family of tyrosine kinase receptors, has been suggested to be a therapeutic target of non-small cell lung cancer (NSCLC) in recent years. The gene discussed is NTRK1; the disease is non-small cell lung carcinoma.